Intelligence Platform
Patents
Browse 446 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11234418
Genetically modified cells, tissues, and organs for treating disease
granted patentUS 11208634
Deimmunized therapeutic compositions and methods
granted patentUS 11147746
Hydrophobic dental surfaces
granted patentUS 11130783
CD40 targeted peptides and uses thereof
granted patentUS 11124541
Chimeric melanocortin ligands and methods of use thereof
granted patentUS 11098101
Therapeutic compounds and methods
granted patentUS 11098100
Therapeutic compounds and methods
granted patentUS 11098109
Single-chain variable fragment anti-CD133 antibodies and uses thereof
granted patentUS 11071787
Topiramate compositions and methods of making and using the same
granted patentUS 11022602
Antibiotic-based conjugates and methods of use thereof
granted patentUS 11014921
Therapeutic compounds and methods of use thereof
granted patentUS 10993959
Methods and compositions for increasing the suppressive function of regulatory T-cells (Tr
granted patentUS 10995317
NK cells exhibiting an adaptive phenotype and methods for preparing and for using
granted patentUS 10993419
Genetically modified cells, tissues, and organs for treating disease
granted patentUS 10981951
Therapeutics for the treatment of glaucoma
granted patentUS 10973844
TALEN-based gene correction
granted patentUS 10973812
Ataxia therapeutic compositions and methods
granted patentUS 10967062
Functionalized nanoparticles and methods of use thereof
granted patentUS 10941433
Neurotransmitter transport in probiotics
granted patentUS 10942183
Methods of detecting progesterone receptor and of detecting an expression level
granted patentUS 10933042
Intravenous baclofen formulations and treatment methods
granted patentUS 10925851
Use of Tosedostat and related compounds as analgesics
granted patentUS 10899793
Melanocortin ligands and methods of use thereof
granted patentUS 10894061
Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppre
granted